Amiodarone-tacrolimus interaction in kidney transplantation

Clinical Nephrology

Volumn 70, Issue 6, 2008, Pages 563-

  Kisters, K ^a   Cziborra, M ^a   Funke, C ^a   Brylak, S ^a   Hausberg, M ^b  

^a ST ANNA HOSPITAL   (Germany)

^b STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CREATININE; CYCLOSPORIN; PREDNISOLONE; TACROLIMUS;

CASE REPORT; CHRONIC GLOMERULONEPHRITIS; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; MALE;

EID: 57349119511     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70563     Document Type: Letter

References (3)

1. Seron D. Management of cardiovascular risk in patients receiving calcineurin inhibitors - a case report. Nephrol Dial Transplant. 2006; 21: 30-33.
2. Nalli N, Stewart-Teixeira L, Dipchand AI. Amiodarone-sirolimus/ tacrolimus interaction in a pediatric heart transplant patient. Pediatr Transplant. 2006; 10: 736-739.
3. Mourad M, Mourad G, Wallemacq P, Garrigue V, Van Bellingen C, Van Kerckhove V, De Meyer M, Malaise J, Eddour DC, Lison D, Squifflet JP, Haufroid V. Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. Transplantation. 2005; 80: 977-984.